SN
Sangeeta Natrajan Iyer
About Sangeeta Natrajan Iyer
Data last updated:
Sangeeta Natrajan Iyer is a Director at Solu Clinipharm Private Limited (since 2012) and Designated Partner at Centrico Pharma Llp (since 2015). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Solu Clinipharm Private Limited at ₹6.24 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Solu Clinipharm Private Limited U74900MH2012PTC226456 | Director | 25 Jan 2012 | 2012 | ₹6.24 Cr (FY 2021) | Active |
 Centrico Pharma Llp AAE-7464 | Designated Partner | 11 Sep 2015 | 2015 | Active |
Board colleagues of Sangeeta Natrajan Iyer
| Name | DIN | Company | Designation |
|---|---|---|---|
| Natrajan Ganesh Iyer | 01840580 | Solu Clinipharm Private Limited , Centrico Pharma Llp | Director |
| Sweety Kumari Pushpraj Chopra | 07256296 | Centrico Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangeeta Natrajan Iyer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangeeta Natrajan Iyer
Sangeeta Natrajan Iyer currently holds 2 directorships: Solu Clinipharm Private Limited (Director, since 25 Jan 2012, revenue ₹6.24 Cr (FY 2021)); Centrico Pharma Llp (Designated Partner, since 11 Sep 2015).
Sangeeta Natrajan Iyer was first appointed on 25 Jan 2012 as Director at Solu Clinipharm Private Limited. The most recent appointment on record is 11 Sep 2015 at Centrico Pharma Llp.
The current boards of Sangeeta Natrajan Iyer's companies include Natrajan Ganesh Iyer (Solu Clinipharm Private Limited), Sweety Kumari Pushpraj Chopra (Centrico Pharma Llp).